New Molecular Insights into the Genetics of Thrombophilia. Resistance to Activated Protein C Caused by Arg506 to Gin Mutation in Factor V as a Pathogenic Risk Factor for Venous Thrombosis
- 1 January 1995
- journal article
- plenary lecture
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 74 (01), 139-148
- https://doi.org/10.1055/s-0038-1642667
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- The Molecular Basis of Blood CoagulationPublished by Elsevier ,2014
- Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosisThe Lancet, 1994
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Resistance to Activated Protein C as a Basis for Venous ThrombosisNew England Journal of Medicine, 1994
- Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia StudyThe Lancet, 1993
- Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.Proceedings of the National Academy of Sciences, 1993
- Regulation of blood coagulation by the protein C systemThe FASEB Journal, 1992
- The protein C anticoagulant pathway.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Incidence and clinical characteristics of hereditary disorders associated with venous thrombosisAmerican Journal of Hematology, 1991
- Deficiencies of Coagulation-Inhibiting and Fibrinolytic Proteins in Outpatients with Deep-Vein ThrombosisNew England Journal of Medicine, 1990